IMR Press / FBL / Volume 7 / Issue 4 / DOI: 10.2741/hatziva

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with Frontiers in Bioscience.

Cellular signaling pathways engaged by the Epstein-Barr virus transforming protein LMP1
Show Less
1 Department of Biology, Aristotle University of Thessaloniki, Thessaloniki 54006, Greece
2 Institute of Immunology, Biomedical Sciences Research Center Al. Fleming, 14-16 Al. Fleming Str., Vari 16672, Greece
Front. Biosci. (Landmark Ed) 2002, 7(4), 319–329;
Published: 1 January 2002

The latent membrane protein 1 (LMP1) of Epstein-Barr virus (EBV) is an essential component of the viral machinery that orchestrates cellular transformation and oncogenesis. The critical role of LMP1 in transformation has been established through recombinant genetic analysis of the EBV genome, ectopic expression in cell lines and transgenic mice and immunohistochemical analysis of EBV- associated tumor specimens. The principal mechanism of LMP1 function is based on mimicry of activated cell surface receptors of the tumor necrosis factor superfamily. LMP1 signaling culminates in the activation of transcription factors NF-κB, AP1 and STAT1/3, which have been tightly linked to prevention of apoptosis and malignant transformation. The molecular mechanisms of LMP1 function will be reviewed in this report.

Nasopharyngeal Carcinoma
Latent Membrane Protein 1
Tumor Necrosis Factor Receptor Associated Factors
Back to top